FAM
Fred Alger Management Portfolio holdings
AUM
$22.3B
1-Year Return
57.87%
This Quarter Return
+7.36%
1 Year Return
+57.87%
3 Year Return
+264.72%
5 Year Return
+406.03%
10 Year Return
+1,631.73%
AUM
$20.9B
AUM Growth
+$846M
(+4.2%)
Cap. Flow
-$231M
Cap. Flow
% of AUM
-1.1%
Top 10 Holdings %
Top 10 Hldgs %
37.91%
Holding
586
New
60
Increased
176
Reduced
234
Closed
47
Top Buys
| 1 |
McDonald's
MCD
|
$218M |
| 2 |
Alibaba
BABA
|
$177M |
| 3 |
Microchip Technology
MCHP
|
$116M |
| 4 |
Illumina
ILMN
|
$95.1M |
| 5 |
Estee Lauder
EL
|
$95M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
$158M |
| 2 |
AGN
Allergan plc
AGN
|
$142M |
| 3 |
Comcast
CMCSA
|
$119M |
| 4 |
Honeywell
HON
|
$116M |
| 5 |
Aptiv
APTV
|
$103M |
Sector Composition
| 1 | Technology | 26.72% |
| 2 | Communication Services | 16% |
| 3 | Healthcare | 14.9% |
| 4 | Consumer Discretionary | 14.14% |
| 5 | Financials | 10.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Cencora
COR
$56.7B
| $349K | ﹤0.01% |
3,694
+3,414
| +1,219% | +$323K |
|
377
Stratasys
SSYS
$871M
| $344K | ﹤0.01% |
14,763
-72,910
| -83% | -$1.7M |
|
378
Merit Medical Systems
MMSI
$5.51B
| $343K | ﹤0.01% |
+9,000
| New | +$343K |
|
379
HCA Healthcare
HCA
$98.5B
| $340K | ﹤0.01% |
3,894
-321
| -8% | -$28K |
|
|
RXDX
380
DELISTED
Ignyta, Inc.
RXDX
| $331K | ﹤0.01% |
+32,000
| New | +$331K |
|
381
Woodward
WWD
$14.6B
| $325K | ﹤0.01% |
4,811
+9
| +0.2% | +$608 |
|
|
WOOF
382
DELISTED
VCA Inc.
WOOF
| $316K | ﹤0.01% |
3,419
-29,488
| -90% | -$2.73M |
|
383
EOG Resources
EOG
$64.4B
| $299K | ﹤0.01% |
3,300
-4,969
| -60% | -$450K |
|
384
Stantec
STN
$12.3B
| $253K | ﹤0.01% |
10,070
| – | – |
|
|
SIOX
385
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $232K | ﹤0.01% |
1,250
| – | – |
|
386
AbbVie
ABBV
$375B
| $232K | ﹤0.01% |
3,200
+3,000
| +1,500% | +$218K |
|
387
Verisk Analytics
VRSK
$37.8B
| $214K | ﹤0.01% |
2,532
-122,408
| -98% | -$10.3M |
|
388
Chevron
CVX
$310B
| $213K | ﹤0.01% |
2,040
-2,150
| -51% | -$224K |
|
|
BPMC
389
DELISTED
Blueprint Medicines
BPMC
| $203K | ﹤0.01% |
+4,000
| New | +$203K |
|
|
AMTD
390
DELISTED
TD Ameritrade Holding Corp
AMTD
| $173K | ﹤0.01% |
4,021
+7
| +0.2% | +$301 |
|
391
PetMed Express
PETS
$63M
| $162K | ﹤0.01% |
+4,000
| New | +$162K |
|
|
ITCI
392
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $161K | ﹤0.01% |
+13,000
| New | +$161K |
|
393
Axalta
AXTA
$6.89B
| $159K | ﹤0.01% |
4,957
| – | – |
|
394
Teladoc Health
TDOC
$1.38B
| $139K | ﹤0.01% |
+4,000
| New | +$139K |
|
|
GBT
395
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $137K | ﹤0.01% |
5,000
-11,000
| -69% | -$301K |
|
396
Euronet Worldwide
EEFT
$3.74B
| $129K | ﹤0.01% |
1,472
-144,351
| -99% | -$12.7M |
|
397
Peapack-Gladstone Financial
PGC
$510M
| $129K | ﹤0.01% |
4,138
| – | – |
|
398
Wabtec
WAB
$33B
| $123K | ﹤0.01% |
1,344
-121
| -8% | -$11.1K |
|
|
TVRD
399
Tvardi Therapeutics, Inc. Common Stock
TVRD
$292M
| $123K | ﹤0.01% |
+222
| New | +$123K |
|
400
Ambarella
AMBA
$3.54B
| $121K | ﹤0.01% |
2,500
| – | – |
|